Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2490 (LINC02490) is a non-coding RNA gene that produces large RNA transcripts longer than 200 nucleotides which do not overlap with protein-coding genes. As a lincRNA, it is part of a genomic class implicated in fine-tuning gene expression, chromatin architecture reorganization, and transcriptional regulation, often with strong tissue specificity. Most lincRNAs, including LINC02490, have not been extensively functionally characterized, and their roles remain an active area of research. Currently, LINC02490 is primarily annotated in genome databases as a non-coding element, with aliases reflecting its identification in transcriptomic studies. No specific disease associations, therapeutic interventions, or biomarker applications are established for this RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2490 (LINC02490).